UPS heralds partnership with Novavax for vaccine distribution and delivery efforts - SCMR
Atlanta-based global transportation and logistics services provider UPS recently announced it has formed a partnership with Novavax, a global biotech company, focused on the distribution and delivery of Novavax’ recently-approved COVID-19 vaccine to 27 European Union countries.
UPS said that the new vaccine is another weapon in the global fight against COVID-19. And it explained that because it does not require ultra-cold refrigeration, it can be more easily delivered to remote and rural areas that don’t have cold chain facilities. What’s more, the company added that UPS Healthcare’s European Network has been keenly focused on vaccine delivery efforts, with UPS having delivered more than 1 billion doses with 99.9% on-time delivery in more than 110 countries.
“UPS is proud to partner with Novavax to distribute its COVID-19 vaccine in the European Union and beyond,” said Wes Wheeler, president of UPS Healthcare, in a statement. “The extensive infrastructure UPS Healthcare has built in the European Union to handle temperature-sensitive products will make this life-saving vaccine and other needed healthcare products quickly available to hundreds of millions of people.”
